Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001696962 | SCV000681066 | pathogenic | not provided | 2018-09-14 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 30735726) |
Ambry Genetics | RCV003159975 | SCV003887559 | pathogenic | Inborn genetic diseases | 2023-01-25 | criteria provided, single submitter | clinical testing | The c.520C>T (p.R174*) alteration, located in exon 6 (coding exon 6) of the MEIS2 gene, consists of a C to T substitution at nucleotide position 520. This changes the amino acid from an arginine (R) to a stop codon at amino acid position 174. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This variant has been reported to be de novo in one individual with cardiac defects, intellectual disability, dysmorphic facial features, and gastroesophageal reflux (Giliberti, 2020). Based on the available evidence, this alteration is classified as pathogenic. |
Genomic Medicine Lab, |
RCV004001218 | SCV004847166 | pathogenic | Cardiac malformation, cleft lip/palate, microcephaly, and digital anomalies | 2023-04-27 | criteria provided, single submitter | clinical testing |